 CAMBRIDGE, Mass., March 02, 2021 GLOBE NEWSWIRE -- Evelo Biosciences Nasdaq:EVLO, a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Tuesday, March 9, 2021 to report its fourth quarter and full year 2020 financial results and discuss business highlights. 